Becton Dickinson & Co. (NYSE:BDX) today announced the total consideration payable in a previously announced tender offer for select senior notes, with an aggregate tender cap of $1.1 billion for all tendered notes, and added that it amended the tender subcaps for select notes.
The Franklin Lakes, N.J.-based company said that the tender offer will apply to its 5% notes due 2040, 4.875% notes due 2044, 4.685% notes due 2044, 3.700% notes due 2027, 3.734% Notes due 2024, 4.669% Notes due 2047 and 2.894% Notes due 2022.
BD said that it amended its tender offer subcaps for a select number of its senior notes, lifting the subcap for its 5% notes due 2040 from $75 million to approximately $175 million, for its 4.685% notes due 2044 from $175 million to $175.002 million and for its 3.700% notes due 2027 from $600 million to $675 million.
The company said that currently, it has $300 million outstanding in 5% notes due 2040, approximately $299.9 million in 4.875% notes due 2044, $1.2 billion in 4.685% notes due 2044 and $2.4 billion in 3.7% notes due 2027, according to an SEC filing.
Last month, BD subsidiary CareFusion agreed to pay $3.3 million to settle civil fraud claims alleging that it sold products without FDA approval, according to a release from the U.S. Attorney’s Office for the Southern District of New York.
